MedPath

Maxiphrine

Brand Name: Maxiphrine

Generic Name: Epinephrine

Active
Registration Number

DRP-13346

Dosage Form

Solution For Injection (IM/IV/SC)

Issuance Date

February 1, 2023

Expiry Date

February 1, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1mg/mL
PackagingType 1 amber colored glass ampoule x 1 mL (Box of 10's).

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EpinephrineActive
Monograph: Epinephrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform